Radius Recycling, Inc. (RDUS)
(Real Time Quote from BATS)
$14.45 USD
+0.03 (0.21%)
Updated Aug 16, 2024 01:40 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Brokerage Reports
[RDUS]
Reports for Purchase
Showing records 61 - 80 ( 169 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Radius Finds a Buyer for Elacestrant; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Tymlos Performs Well, Covid-19 Creates Some Uncertainty
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Unexpected, Though Understandable Leadership Transition
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Strong Quarter Matched to Strong Outlook; Target to $28, Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department